Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
PERPETUAL SALES INC. (PSVQ) Makes Digital Content Work at the Point of Purchase
PERPETUAL SALES INC. (PSVQ) Explores Smart Retail for Everyday Life
PERPETUAL SALES INC. (PSVQ) Explores Connecting Inventory, Equipment and Daily Tasks
International Retreat Association™ Hosts Free Retreat Industry Conference for Retreat Leaders on October 22
Does FXP Pay? FXP Answers the 5 Questions Traders Ask Before Trusting a Prop Firm
‘I wanted to create the female version of a man’s suit’: how Roland Mouret’s Galaxy dress took over the world
10 nightime attractions around the UK this autumn
Move over memecoins: Crypto ‘meme games’ coming, bagholders and all
New Metaphysical Trilogy Shatters the Illusion of Time, Separation, and the Human Soul
New Theological Analysis Challenges Millennia-Old Interpretation of the Garden of Eden
Dame Judi Dench: ‘I can’t do a play, a film or read any more’
Websites taken offline in race to patch PHP security flaw
Armies of lawyers prepare to stop interference in US midterms
Hackers Exploited the PHP Vulnerabilities Days Before They Were Patched
PHP Foundation admits ‘structural failure’ delayed critical security fix
Four locations in the running to be UK City of Culture 2029
Mark Zuckerberg Agrees to Stay in California Despite Billionaires’ Tax Ballot Measure
Matrix Insurance Launches Free Insurance Guide Website
Independent Company Reflects on Nearly Three Decades of Experience and Customer Service
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute